{"id":"https://openalex.org/W2281489950","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.7204","title":"Randomized phase II trial of pemetrexed with either cisplatin or carboplatin in extensive stage small cell lung cancer","display_name":"Randomized phase II trial of pemetrexed with either cisplatin or carboplatin in extensive stage small cell lung cancer","publication_year":2004,"publication_date":"2004-07-15","ids":{"openalex":"https://openalex.org/W2281489950","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.7204","mag":"2281489950"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2004.22.14_suppl.7204","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.7204","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.7204","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078629724","display_name":"Mark A. Socinski","orcid":"https://orcid.org/0000-0003-2915-9325","observed_orcids":["https://orcid.org/0000-0003-2915-9325","https://orcid.org/0000-0002-8213-0137"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I2801272649","display_name":"Ronald Reagan UCLA Medical Center","ror":"https://ror.org/04k3jt835","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801272649"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. A. Socinski","raw_affiliation_strings":["University of North Carolina, Chapel Hill, NC; US Oncology, Houston, TX; Florida Cancer Spec, Fort Meyers, FL; Alamance Regional Medical Center, Burlington, NC; Trident Palmetto Hem/Onc, Charleston, SC; UCLA Medical Center, Los Angeles, CA; Eli Lilly Oncology, Carmel, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina, Chapel Hill, NC; US Oncology, Houston, TX; Florida Cancer Spec, Fort Meyers, FL; Alamance Regional Medical Center, Burlington, NC; Trident Palmetto Hem/Onc, Charleston, SC; UCLA Medical Center, Los Angeles, CA; Eli Lilly Oncology, Carmel, IN","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I161318765","https://openalex.org/I2801272649","https://openalex.org/I2801403999"]}]},{"author_position":"middle","author":{"id":null,"display_name":"C. Weissman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I2801272649","display_name":"Ronald Reagan UCLA Medical Center","ror":"https://ror.org/04k3jt835","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801272649"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Weissman","raw_affiliation_strings":["University of North Carolina, Chapel Hill, NC; US Oncology, Houston, TX; Florida Cancer Spec, Fort Meyers, FL; Alamance Regional Medical Center, Burlington, NC; Trident Palmetto Hem/Onc, Charleston, SC; UCLA Medical Center, Los Angeles, CA; Eli Lilly Oncology, Carmel, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina, Chapel Hill, NC; US Oncology, Houston, TX; Florida Cancer Spec, Fort Meyers, FL; Alamance Regional Medical Center, Burlington, NC; Trident Palmetto Hem/Onc, Charleston, SC; UCLA Medical Center, Los Angeles, CA; Eli Lilly Oncology, Carmel, IN","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I161318765","https://openalex.org/I2801272649","https://openalex.org/I2801403999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111656761","display_name":"Lowell L. Hart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I2801272649","display_name":"Ronald Reagan UCLA Medical Center","ror":"https://ror.org/04k3jt835","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801272649"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. L. Hart","raw_affiliation_strings":["University of North Carolina, Chapel Hill, NC; US Oncology, Houston, TX; Florida Cancer Spec, Fort Meyers, FL; Alamance Regional Medical Center, Burlington, NC; Trident Palmetto Hem/Onc, Charleston, SC; UCLA Medical Center, Los Angeles, CA; Eli Lilly Oncology, Carmel, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina, Chapel Hill, NC; US Oncology, Houston, TX; Florida Cancer Spec, Fort Meyers, FL; Alamance Regional Medical Center, Burlington, NC; Trident Palmetto Hem/Onc, Charleston, SC; UCLA Medical Center, Los Angeles, CA; Eli Lilly Oncology, Carmel, IN","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I161318765","https://openalex.org/I2801272649","https://openalex.org/I2801403999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062335050","display_name":"J. K. Choksi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I2801272649","display_name":"Ronald Reagan UCLA Medical Center","ror":"https://ror.org/04k3jt835","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801272649"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. K. Choksi","raw_affiliation_strings":["University of North Carolina, Chapel Hill, NC; US Oncology, Houston, TX; Florida Cancer Spec, Fort Meyers, FL; Alamance Regional Medical Center, Burlington, NC; Trident Palmetto Hem/Onc, Charleston, SC; UCLA Medical Center, Los Angeles, CA; Eli Lilly Oncology, Carmel, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina, Chapel Hill, NC; US Oncology, Houston, TX; Florida Cancer Spec, Fort Meyers, FL; Alamance Regional Medical Center, Burlington, NC; Trident Palmetto Hem/Onc, Charleston, SC; UCLA Medical Center, Los Angeles, CA; Eli Lilly Oncology, Carmel, IN","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I161318765","https://openalex.org/I2801272649","https://openalex.org/I2801403999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083652102","display_name":"Charles Holladay","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I2801272649","display_name":"Ronald Reagan UCLA Medical Center","ror":"https://ror.org/04k3jt835","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801272649"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Holladay","raw_affiliation_strings":["University of North Carolina, Chapel Hill, NC; US Oncology, Houston, TX; Florida Cancer Spec, Fort Meyers, FL; Alamance Regional Medical Center, Burlington, NC; Trident Palmetto Hem/Onc, Charleston, SC; UCLA Medical Center, Los Angeles, CA; Eli Lilly Oncology, Carmel, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina, Chapel Hill, NC; US Oncology, Houston, TX; Florida Cancer Spec, Fort Meyers, FL; Alamance Regional Medical Center, Burlington, NC; Trident Palmetto Hem/Onc, Charleston, SC; UCLA Medical Center, Los Angeles, CA; Eli Lilly Oncology, Carmel, IN","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I161318765","https://openalex.org/I2801272649","https://openalex.org/I2801403999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113698410","display_name":"Diane Prager","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I2801272649","display_name":"Ronald Reagan UCLA Medical Center","ror":"https://ror.org/04k3jt835","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801272649"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Prager","raw_affiliation_strings":["University of North Carolina, Chapel Hill, NC; US Oncology, Houston, TX; Florida Cancer Spec, Fort Meyers, FL; Alamance Regional Medical Center, Burlington, NC; Trident Palmetto Hem/Onc, Charleston, SC; UCLA Medical Center, Los Angeles, CA; Eli Lilly Oncology, Carmel, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina, Chapel Hill, NC; US Oncology, Houston, TX; Florida Cancer Spec, Fort Meyers, FL; Alamance Regional Medical Center, Burlington, NC; Trident Palmetto Hem/Onc, Charleston, SC; UCLA Medical Center, Los Angeles, CA; Eli Lilly Oncology, Carmel, IN","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I161318765","https://openalex.org/I2801272649","https://openalex.org/I2801403999"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016064449","display_name":"Coleman K. Obasaju","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I2801272649","display_name":"Ronald Reagan UCLA Medical Center","ror":"https://ror.org/04k3jt835","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801272649"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. K. Obasaju","raw_affiliation_strings":["University of North Carolina, Chapel Hill, NC; US Oncology, Houston, TX; Florida Cancer Spec, Fort Meyers, FL; Alamance Regional Medical Center, Burlington, NC; Trident Palmetto Hem/Onc, Charleston, SC; UCLA Medical Center, Los Angeles, CA; Eli Lilly Oncology, Carmel, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina, Chapel Hill, NC; US Oncology, Houston, TX; Florida Cancer Spec, Fort Meyers, FL; Alamance Regional Medical Center, Burlington, NC; Trident Palmetto Hem/Onc, Charleston, SC; UCLA Medical Center, Los Angeles, CA; Eli Lilly Oncology, Carmel, IN","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I161318765","https://openalex.org/I2801272649","https://openalex.org/I2801403999"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"14_suppl","first_page":"7204","last_page":"7204"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pemetrexed","display_name":"pemetrexed","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9629999995231628},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":1.0},{"id":"https://openalex.org/keywords/extensive-stage-small-cell-lung-cancer","display_name":"extensive-stage small cell lung cancer","score":0.9769999980926514},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.7360000014305115},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7139999866485596},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.7329999804496765},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6959999799728394},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8270000219345093}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.917357325553894},{"id":"https://openalex.org/C2777240266","wikidata":"https://www.wikidata.org/wiki/Q415220","display_name":"Pemetrexed","level":4,"score":0.9143775105476379},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.8121209740638733},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6440121531486511},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5494371056556702},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.518601655960083},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4923509359359741},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.4891086220741272},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4695625603199005},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.4471493065357208},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.41389793157577515},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.4138125479221344},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.39819756150245667},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.37489908933639526},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3660743832588196},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2982805371284485}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2004.22.14_suppl.7204","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.7204","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.7204","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"doi:10.1200/jco.2004.22.90140.7204","doi":"https://doi.org/10.1200/jco.2004.22.90140.7204","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.90140.7204","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2105527005","https://openalex.org/W2288014069","https://openalex.org/W2049872779","https://openalex.org/W2083424818","https://openalex.org/W1988454321","https://openalex.org/W2155723257","https://openalex.org/W1985293042","https://openalex.org/W2226373164","https://openalex.org/W1996141967","https://openalex.org/W2340276103"],"abstract_inverted_index":{"7204":[0],"Background:":[1],"Pemetrexed":[2],"(PEM,":[3],"ALIMTA,":[4],"Eli":[5,289,293,297,301],"Lilly":[6,290,294,298,302],"and":[7,38,110,145,160,181,210,235,259],"Company,":[8],"Indianapolis,":[9],"IN)":[10],"is":[11,221],"synergistic":[12],"with":[13,23,57,79,244],"platinum-based":[14],"compounds":[15],"in":[16,21,29,35,43,55,125,216,237],"preclinical":[17],"models.":[18],"Clinical":[19],"activity":[20,54],"combination":[22],"the":[24,166,263,270],"platinums":[25],"has":[26],"been":[27,123],"demonstrated":[28],"a":[30,80,98,118,185,193,240],"single":[31],"Phase":[32],"3":[33],"trial":[34],"pleural":[36],"mesothelioma":[37],"four":[39],"phase":[40,70],"2":[41,182],"trials":[42],"non-small":[44],"cell":[45,61],"lung":[46,62],"cancer.":[47],"PEM-platinum":[48],"doublets":[49],"may":[50],"also":[51],"show":[52],"clinical":[53,72],"patients":[56,74,104,121,168,191],"extensive":[58],"stage":[59],"small":[60],"cancer":[63],"(ES-SCLC).":[64],"Methods:":[65],"In":[66],"this":[67,126],"multi-center":[68],"randomized":[69],"II":[71],"trial,":[73],"received":[75,105],"PEM":[76,142,150],"500":[77],"mg/m2":[78],"platinum":[81],"compound":[82],"(carboplatin":[83],"AUC":[84],"5":[85],"or":[86,247,275,278],"cisplatin":[87,144],"75":[88],"mg/m2).":[89],"Treatment":[90],"was":[91,137,163],"administered":[92],"once":[93],"every":[94],"21":[95,133,155],"days":[96],"for":[97,132,141,149,170,184],"maximum":[99],"of":[100,117,188,213],"6":[101,179],"cycles.":[102],"All":[103],"folic":[106],"acid,":[107],"vitamin":[108],"B12,":[109],"steroid":[111],"prophylaxis.":[112],"Results:":[113],"So":[114],"far,":[115],"47":[116],"planned":[119],"72":[120],"have":[122,239],"accrued":[124],"study.":[127],"Results":[128],"are":[129],"currently":[130],"available":[131],"patients.":[134],"Median":[135],"age":[136],"61.0":[138],"years":[139,147],"(range=53\u201374)":[140],"+":[143,151],"65.0":[146],"(range=54\u201375)":[148],"carboplatin.":[152],"For":[153],"all":[154,212],"patients,":[156],"performance":[157],"status":[158],"0:1=24%:62%":[159],"histological:cytological":[161],"diagnosis":[162],"71%:29%.":[164],"Of":[165],"17":[167],"evaluable":[169],"tumor":[171],"response,":[172,257],"there":[173],"were":[174],"0":[175],"CRs,":[176],"9":[177],"PRs,":[178],"SDs,":[180],"PDs":[183],"response":[186,252],"rate":[187,253],"55%.":[189],"Two":[190],"experienced":[192],"Grade":[194,199],"3/4":[195,200],"serious":[196,201],"adverse":[197,202],"event.":[198],"events":[203],"included":[204],"neutropenia,":[205],"nausea,":[206],"vomiting,":[207],"pneumonia,":[208],"dehydration,":[209],"hyponatremia,":[211],"which":[214],"occurred":[215],"1":[217],"patient.":[218],"The":[219,250],"data":[220,231,261],"too":[222],"premature":[223],"to":[224],"estimate":[225],"survival":[226],"outcomes.":[227],"Conclusions:":[228],"This":[229],"preliminary":[230,251],"suggests":[232],"that":[233],"PEM+CIS":[234],"PEM+CARBO":[236],"ES-SCLC":[238],"favorable":[241],"toxicity":[242,258],"profile,":[243],"few":[245],"hematologic":[246],"nonhematologic":[248],"toxicities.":[249],"appears":[254],"promising.":[255],"Additional":[256],"time-to-event":[260],"from":[262],"completed":[264],"study":[265],"will":[266],"be":[267],"presented":[268],"at":[269],"meeting.":[271],"Author":[272],"Disclosure":[273],"Employment":[274],"Leadership":[276],"Consultant":[277],"Advisory":[279],"Stock":[280],"Ownership":[281],"Honoraria":[282],"Research":[283],"Funding":[284],"Expert":[285],"Testimony":[286],"Other":[287],"Remuneration":[288],"&":[291,295,299,303],"Co.":[292,296,300,304]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}